IDCareLive

CME Speakers

Invasive Fungal Infections

  • Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA

    Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA

    Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA

    Deputy Head, Division of Internal Medicine

    Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA is the Frances King Black Endowed Professor and Deputy Head-Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center. He is also an adjunct professor at Baylor College of Medicine and University of Houston College of Pharmacy in Houston Texas. He received his medical degree Summa Cum Laude from the National and Kapodistrian University of Athens in Greece. Dr. Kontoyiannis also completed a post-doctoral clinical research fellowship at the Section of Infectious Diseases at The University of Texas MD Anderson Cancer Center in Houston, TX, followed by training in Internal Medicine at Baylor College of Medicine in Houston, TX, where he served as a Chief Medical Resident. He was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a Master in Clinical Sciences from Harvard Medical School in Boston. He spent 3 years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program. Dr. Kontoyiannis has authored more than 450 peer-reviewed manuscripts and been invited to give over 150 lectures in international conferences and prestigious institutions in US and abroad. He serves as an associate editor for Mycoses and J of Infection and sits in the editorial Boards of Antimicrobial Agents & Chemotherapy, JID. Transplantation Infectious Diseases and he is a reviewer for several other peer-reviewed journals in Infectious Diseases ,Oncology and Hematology. An international expert in clinical and experimental mycology, and the top three most highly cited investigators in the area of mycology with over 450 peer reviwed manuscripts and over 27000 citations. He is a fellow of the American College of Physicians and the Infectious Diseases Society of America. He is the recipient of many awards such as the 2004 American Society for Microbiology award for Outstanding Research in the Pathogenesis of Microbial Diseases (mentor), the America's Top Physicians in from Consumer’s Research Council of America and The University of Texas MD Anderson Cancer Center 2004 Faculty E. N Cobb Scholar Award, Faculty Achievement Award, M. D. Anderson Cancer Center, 2007, The Distinguished Clinical Faculty Mentoring Award of at MD Anderson Cancer Center, 2012, The Billy Cooper Memorial award from The Medical Mycology Society of Americas (2013), America’s Top doctors (2015), The Drouhet Medal from the European Confederation of Medical Mycology (2015). He is the president elect of Immunocompromised Host Society (2016-2018).
  • George R. Thompson, MD

    George R. Thompson, MD

    George R. Thompson, MD

    Associate Professor of Medicine

    Dr. Thompson is Assistant Professor of Clinical Medicine at the University of California, Davis, School of Medicine with a joint appointment in the Departments of Medical Microbiology and Immunology, and Internal Medicine, Division of Infectious Diseases. Dr. Thompson specializes in the care of patients with invasive fungal infections and has research interest in fungal diagnostics and host immunogenetics. His current research focuses on the host-pathogen interaction of humans and both Coccidioides spp. (the agent of “Valley Fever”), and Cryptococcus spp. Dr. Thompson has served on the IDSA Journal Club which is a committee comprised of 12 panelists who select key papers for review and compose a summary of important articles that is published in the internationally disseminated monthly IDSA News. Additionally, he is a member of the Coccidioidomycosis Study Group Planning Committee, and as Co-chair of the Mycoses Study Group - a committee responsible for the development of content and dissemination of materials to practitioners across the United States, planning of the mycology content at yearly meetings (IDSA and ICAAC), and the design of clinical trials.
  • Thomas Patterson, MD

    Thomas Patterson, MD

    Thomas Patterson, MD

    Division Head and Division Chief, Infectious Diseases

    Dr. Thomas F. Patterson received his Bachelor of Arts degree from Baylor University, in Waco, Texas and his Medical Doctor from the University of Texas Medical School at Houston, Texas. He completed his internship and residency at Vanderbilt University Medical School, in Nashville, Tennessee and Yale-New Haven Hospital, and a fellowship in infectious diseases at Yale University School of Medicine, New Haven, Connecticut where he also served as an Assistant Professor of Medicine. Dr. Patterson currently is a Professor of Medicine and Chief, Division of Infectious Diseases at the University of Texas Health Science Center in San Antonio, Texas. He is also Director of the San Antonio Center for Medical Mycology. He has extensive experience in invasive fungal infections. His clinical and research interests focus on the diagnosis and treatment of fungal diseases particularly in immunocompromised hosts. He has been involved in developing new antifungal drugs and in clinical trials of new antifungal compounds. Dr. Patterson has published and lectured extensively on fungal infections. He has served as member of the American Board of Internal Medicine, Subspecialty Committee for Infectious Diseases, a Fellow of the American College of Physicians, Past-President of the Texas Infectious Disease Society, and current President, Immunocompromised Host Society.
  • Nathan P. Wiederhold, PharmD, FCCP

    Nathan P. Wiederhold, PharmD, FCCP

    Nathan P. Wiederhold, PharmD, FCCP

    Associate Professor, Departments of Pathology & Medicine/Infectious Diseases

    Dr. Nathan P. Wiederhold is Associate Professor of Pathology and Medicine/Infectious Diseases at the University of Texas Health Science Center at San Antonio, and Adjoint Associate Professor of Pharmacy, at the University of Texas at Austin College of Pharmacy. Dr. Wiederhold received his Pharm.D. from the University of Texas at Austin in 2000, followed by pharmacy practice and infectious diseases clinical residencies at Barnes Jewish Hospital, St. Louis, Missouri. He then completed a two-year research fellowship in antifungal pharmacology/medical mycology at the University of Houston and UT MD Anderson Cancer in Houston, Texas. Dr. Wiederhold then joined the faculty of the University of Texas at Austin and the University of Texas Health Science Center at San Antonio in 2004. He then became the director of the Fungus Testing Laboratory in 2013. Dr. Wiederhold’s clinical and research areas include medical mycology, antifungal susceptibility and resistance, and antifungal therapeutic drug monitoring. He has over 100 peer-reviewed publications in this area, and his work has been supported by the National Institutes of Health, various professional organizations, and industry.

Gram-Negative Infections

  • Trevor Van Schooneveld, MD, FACP

    Trevor Van Schooneveld, MD, FACP

    Trevor Van Schooneveld, MD, FACP

    Associate Professor, Division of Infectious Disease

    Dr. Van Schooneveld is an Associate Professor in the Division of Infectious Disease, Department of Internal Medicine at the University of Nebraska Medical Center in Omaha, Nebraska. He received his undergraduate degree in Biochemistry from Colorado State University and his M.D. from the University of Nebraska Medical Center. He completed his residency in Internal Medicine along with a chief resident year at UNMC. He then did his fellowship training in Infectious Disease at Creighton University Medical Center. Dr. Van Schooneveld is the Medical Director of the Antimicrobial Stewardship Program and the Associate Medical Director of the Department of Infection Control and Epidemiology at the Nebraska Medical Center. He also serves as the Program Director for the UNMC Infectious Disease Fellowship Program. His research interests include antimicrobial stewardship, C. difficile infection, and multidrug-resistant pathogens.

Gram-Positive Skin Infections

  • Loren G. Miller, MD, MPH

    Loren G. Miller, MD, MPH

    Loren G. Miller, MD, MPH

    Professor of Medicine

    Loren Miller, MD, MPH, is professor of medicine at the David Geffen School of Medicine at University of California, Los Angeles. He is a faculty member in the Division of Adult Infectious Diseases at Harbor-UCLA Medical Center and serves as the director of the Infection Control Program at Harbor-UCLA. Dr Miller received his medical degree from Columbia University College of Physicians and Surgeons in New York, and his Masters in Public Health from the University of California, Los Angeles. He completed an internship and residency at Harbor-UCLA Medical Center, a fellowship at the UCLA Multicampus Program in infectious diseases and microbial pathogenesis, and a fellowship with the UCLA/VA Multicampus Program in health services research. Dr Miller’s primary research interests include clinical outcomes, epidemiology, and molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections and skin infections. He has served as an investigator and principal investigator on many NIH, CDC, and AHQR grants related to treatment and prevention of MRSA and CA-MRSA, and has performed investigations related to HIV infection, urinary tract infections, Hepatitis B and C, and other infectious diseases topics. Dr Miller has authored several manuscripts relating to clinical and epidemiologic issues, and is an author on over 70 peer-reviewed manuscripts and book chapters.
  • David Talan, MD, FACEP, FAAEM, FIDSA

    David Talan, MD, FACEP, FAAEM, FIDSA

    David Talan, MD, FACEP, FAAEM, FIDSA

    Department of Medicine

    Dr. Talan received his medical degree from the University of Illinois Medical College in Chicago. He completed his residencies in Internal and Emergency Medicine and fellowship in Infectious Diseases at the University of California Los Angeles (UCLA) and its associated medical centers. He is board certified in Internal Medicine, Emergency Medicine, and Infectious Diseases.

    Dr. Talan was Chairman of the Olive View UCLA Department of Emergency Medicine from 1993 to 2014. He is faculty of the Department of Emergency Medicine and Department of Medicine, Division of Infectious Diseases at Olive View UCLA Medical Center. He is Professor of Medicine in Residence (Emeritus) at The David Geffen School of Medicine at UCLA. He is a Fellow of the American College of Emergency Physicians and the Infectious Diseases Society of America. Dr. Talan serves on the editorial boards of the Annals of Emergency Medicine, Emergency Medicine News, and Pediatric Emergency Care and is a reviewer for many journals including Clinical Infectious Diseases, JAMA, and The Medical Letter.

Vaccines

  • Elizabeth D. Barnett, MD

    Elizabeth D. Barnett, MD

    Elizabeth D. Barnett, MD

    Professor of Pediatrics

    Elizabeth D. Barnett, MD, is professor of pediatrics at the Boston University School of Medicine. She earned her medical degree from the Boston University School of Medicine, completed her residency at Boston City Hospital and Children’s Hospital, Boston, and completed a pediatric infectious disease fellowship at Boston City Hospital. Dr Barnett is board certified in pediatrics and pediatric infectious disease, and holds special interest in immigrant and refugee health, travel medicine, and immunizations.
  • Lin Hwei Chen, MD

    Lin Hwei Chen, MD

    Lin Hwei Chen, MD

    Director, Travel Medicine Center

    Lin H. Chen, MD, FACP, FASTMH, is the director of the Travel Medicine Center at Mount Auburn Hospital in Cambridge, Massachusetts, and associate professor of medicine at Harvard Medical School. She is a fellow of the American College of Physicians and the American Society of Tropical Medicine and Hygiene (ASTMH), serves on the Professional Education and Training Committee of the International Society of Travel Medicine (ISTM), and is an associate chair of the Scientific Program Committee for CISTM15 in Barcelona, Spain. Dr Chen is a member of the ASTMH’s Certificate Examination Committee and has contributed to the Journal of Travel Medicine, Current Infectious Disease Reports and Travel Medicine and Infectious Diseases, as well as the book Infectious Diseases: A Geographic Guide.

HIV Adherence

  • Paul E. Sax, MD

    Paul E. Sax, MD

    Paul E. Sax, MD

    Professor of Medicine

    Paul E. Sax, MD, is clinical director of the Division of Infectious Diseases and the HIV Program at Brigham and Women's Hospital (BWH), and professor of medicine at Harvard Medical School in Boston, Massachusetts. His ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. Dr Sax is presently the principal investigator at the BWH AIDS Clinical Trials Unit, a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group, and editor-in-chief of Open Forum Infectious Diseases. He earned his MD from Harvard Medical School, completed an internal medicine residency at BWH, and an infectious diseases fellowship at Massachusetts General Hospital.
  • John T. Brooks, MD

    John T. Brooks, MD

    John T. Brooks, MD

    Medical Epidemiologist, Division of HIV/AIDS Prevention

    John T. Brooks, MD is a medical epidemiologist with the Centers for Disease Control and Prevention in the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. He leads the Epidemiology Research Team in the CDC’s Division of HIV/AIDS Prevention that sponsors the HIV Outpatient Study which, since 1993, tracks the health of individuals living with HIV infection to improve prevention and treatment services. Dr Brooks is a nationally known expert in HIV-related opportunistic infections, complications of long-term survival and aging with HIV, and the use HIV medicines to prevent HIV transmission. He serves on numerous national HIV guidelines committees and has authored or coauthored over 140 peer-reviewed publications.
  • Linda Spooner, PharmD, RPh, BCPS, FASHP

    Linda Spooner, PharmD, RPh, BCPS, FASHP

    Linda Spooner, PharmD, RPh, BCPS, FASHP

    Professor of Pharmacy Practice

    Linda Spooner, PharmD, RPh, BCPS, FASHP, is professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences (MCPHS) School of Pharmacy-Worcester/Manchester and a clinical pharmacy specialist in infectious diseases at Saint Vincent Hospital in Worcester, Massachusetts. She conducts research in HIV pharmacotherapy, including assessment of medication errors with antiretroviral therapy in hospitalized patients, and spearheads initiatives to facilitate safe and appropriate use of antiretroviral therapy within the hospital setting. Dr Spooner is a fellow of the American Society of Health-System Pharmacists, is published in peer-reviewed journals, writes textbook chapters on antiretroviral therapy, and provides continuing education sessions for pharmacists.

Zika Virus Update

  • Joanne Cono, MD, ScM

    Joanne Cono, MD, ScM

    Joanne Cono, MD, ScM

    Director, Office of Science Quality

    Joanne Cono is the Director of CDC’s Office of Science Quality. A board-certified pediatrician trained at the Children’s Hospital of Pittsburgh, Dr. Cono completed a Community Pediatrics and Child Advocacy fellowship at the Albert Einstein College of Medicine and has practiced pediatrics in the New York City homeless shelter system and at Egleston Children’s Hospital in Atlanta. She has a Master of Science degree in Vaccine Science and International Health from the Johns Hopkins School of Hygiene and Public Health, was a fellow in public health genetics at CDC, and a visiting faculty member at the University of Tartu in Estonia, teaching Epidemiology and Pediatrics. Dr. Cono joined CDC in 2000 as a medical epidemiologist in the National Immunization Program where she worked on childhood vaccine-preventable diseases and as an Associate Director for Science. She also has been an Associate Director for Science and Senior Medical Officer in the CDC Coordinating Office for Terrorism Preparedness and Emergency Response, as well as in the Bioterrorism Preparedness and Response Program of the National Center for Infectious Diseases where she was a lead for CDC’s smallpox vaccination and preparedness, as well as other bioterrorism preparedness activities. She was the lead of the Clinician Communications Team in CDC’s Emergency Communications System (ECS), developing emergency clinical guidance for medical and health professionals across the nation. More recently, Dr. Cono served as Senior Advisor for Global Health and as Senior Advisor for Science to the Director of CDC’s former Coordinating Center for Infectious Diseases, and as Senior Advisor for Science Integration to the Director of the current Office of Infectious Diseases. She has participated in numerous CDC public health emergency responses and led the Epidemiologic Response Team during the U.S. monkeypox outbreak response of 2003, and was Chief Health Officer in CDC’s emergency response to the 2010 earthquake in Haiti. Her areas of interest are emerging infectious diseases, emergency response, global health, and immunization.

All Speakers

  • Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA

    Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA

    Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA

    Deputy Head, Division of Internal Medicine

    Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA is the Frances King Black Endowed Professor and Deputy Head-Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center. He is also an adjunct professor at Baylor College of Medicine and University of Houston College of Pharmacy in Houston Texas. He received his medical degree Summa Cum Laude from the National and Kapodistrian University of Athens in Greece. Dr. Kontoyiannis also completed a post-doctoral clinical research fellowship at the Section of Infectious Diseases at The University of Texas MD Anderson Cancer Center in Houston, TX, followed by training in Internal Medicine at Baylor College of Medicine in Houston, TX, where he served as a Chief Medical Resident. He was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a Master in Clinical Sciences from Harvard Medical School in Boston. He spent 3 years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program. Dr. Kontoyiannis has authored more than 450 peer-reviewed manuscripts and been invited to give over 150 lectures in international conferences and prestigious institutions in US and abroad. He serves as an associate editor for Mycoses and J of Infection and sits in the editorial Boards of Antimicrobial Agents & Chemotherapy, JID. Transplantation Infectious Diseases and he is a reviewer for several other peer-reviewed journals in Infectious Diseases ,Oncology and Hematology. An international expert in clinical and experimental mycology, and the top three most highly cited investigators in the area of mycology with over 450 peer reviwed manuscripts and over 27000 citations. He is a fellow of the American College of Physicians and the Infectious Diseases Society of America. He is the recipient of many awards such as the 2004 American Society for Microbiology award for Outstanding Research in the Pathogenesis of Microbial Diseases (mentor), the America's Top Physicians in from Consumer’s Research Council of America and The University of Texas MD Anderson Cancer Center 2004 Faculty E. N Cobb Scholar Award, Faculty Achievement Award, M. D. Anderson Cancer Center, 2007, The Distinguished Clinical Faculty Mentoring Award of at MD Anderson Cancer Center, 2012, The Billy Cooper Memorial award from The Medical Mycology Society of Americas (2013), America’s Top doctors (2015), The Drouhet Medal from the European Confederation of Medical Mycology (2015). He is the president elect of Immunocompromised Host Society (2016-2018).
  • George R. Thompson, MD

    George R. Thompson, MD

    George R. Thompson, MD

    Associate Professor of Medicine

    Dr. Thompson is Assistant Professor of Clinical Medicine at the University of California, Davis, School of Medicine with a joint appointment in the Departments of Medical Microbiology and Immunology, and Internal Medicine, Division of Infectious Diseases. Dr. Thompson specializes in the care of patients with invasive fungal infections and has research interest in fungal diagnostics and host immunogenetics. His current research focuses on the host-pathogen interaction of humans and both Coccidioides spp. (the agent of “Valley Fever”), and Cryptococcus spp. Dr. Thompson has served on the IDSA Journal Club which is a committee comprised of 12 panelists who select key papers for review and compose a summary of important articles that is published in the internationally disseminated monthly IDSA News. Additionally, he is a member of the Coccidioidomycosis Study Group Planning Committee, and as Co-chair of the Mycoses Study Group - a committee responsible for the development of content and dissemination of materials to practitioners across the United States, planning of the mycology content at yearly meetings (IDSA and ICAAC), and the design of clinical trials.
  • Thomas Patterson, MD

    Thomas Patterson, MD

    Thomas Patterson, MD

    Division Head and Division Chief, Infectious Diseases

    Dr. Thomas F. Patterson received his Bachelor of Arts degree from Baylor University, in Waco, Texas and his Medical Doctor from the University of Texas Medical School at Houston, Texas. He completed his internship and residency at Vanderbilt University Medical School, in Nashville, Tennessee and Yale-New Haven Hospital, and a fellowship in infectious diseases at Yale University School of Medicine, New Haven, Connecticut where he also served as an Assistant Professor of Medicine. Dr. Patterson currently is a Professor of Medicine and Chief, Division of Infectious Diseases at the University of Texas Health Science Center in San Antonio, Texas. He is also Director of the San Antonio Center for Medical Mycology. He has extensive experience in invasive fungal infections. His clinical and research interests focus on the diagnosis and treatment of fungal diseases particularly in immunocompromised hosts. He has been involved in developing new antifungal drugs and in clinical trials of new antifungal compounds. Dr. Patterson has published and lectured extensively on fungal infections. He has served as member of the American Board of Internal Medicine, Subspecialty Committee for Infectious Diseases, a Fellow of the American College of Physicians, Past-President of the Texas Infectious Disease Society, and current President, Immunocompromised Host Society.
  • Nathan P. Wiederhold, PharmD, FCCP

    Nathan P. Wiederhold, PharmD, FCCP

    Nathan P. Wiederhold, PharmD, FCCP

    Associate Professor, Departments of Pathology & Medicine/Infectious Diseases

    Dr. Nathan P. Wiederhold is Associate Professor of Pathology and Medicine/Infectious Diseases at the University of Texas Health Science Center at San Antonio, and Adjoint Associate Professor of Pharmacy, at the University of Texas at Austin College of Pharmacy. Dr. Wiederhold received his Pharm.D. from the University of Texas at Austin in 2000, followed by pharmacy practice and infectious diseases clinical residencies at Barnes Jewish Hospital, St. Louis, Missouri. He then completed a two-year research fellowship in antifungal pharmacology/medical mycology at the University of Houston and UT MD Anderson Cancer in Houston, Texas. Dr. Wiederhold then joined the faculty of the University of Texas at Austin and the University of Texas Health Science Center at San Antonio in 2004. He then became the director of the Fungus Testing Laboratory in 2013. Dr. Wiederhold’s clinical and research areas include medical mycology, antifungal susceptibility and resistance, and antifungal therapeutic drug monitoring. He has over 100 peer-reviewed publications in this area, and his work has been supported by the National Institutes of Health, various professional organizations, and industry.
  • Trevor Van Schooneveld, MD, FACP

    Trevor Van Schooneveld, MD, FACP

    Trevor Van Schooneveld, MD, FACP

    Associate Professor, Division of Infectious Disease

    Dr. Van Schooneveld is an Associate Professor in the Division of Infectious Disease, Department of Internal Medicine at the University of Nebraska Medical Center in Omaha, Nebraska. He received his undergraduate degree in Biochemistry from Colorado State University and his M.D. from the University of Nebraska Medical Center. He completed his residency in Internal Medicine along with a chief resident year at UNMC. He then did his fellowship training in Infectious Disease at Creighton University Medical Center. Dr. Van Schooneveld is the Medical Director of the Antimicrobial Stewardship Program and the Associate Medical Director of the Department of Infection Control and Epidemiology at the Nebraska Medical Center. He also serves as the Program Director for the UNMC Infectious Disease Fellowship Program. His research interests include antimicrobial stewardship, C. difficile infection, and multidrug-resistant pathogens.
  • Loren G. Miller, MD, MPH

    Loren G. Miller, MD, MPH

    Loren G. Miller, MD, MPH

    Professor of Medicine

    Loren Miller, MD, MPH, is professor of medicine at the David Geffen School of Medicine at University of California, Los Angeles. He is a faculty member in the Division of Adult Infectious Diseases at Harbor-UCLA Medical Center and serves as the director of the Infection Control Program at Harbor-UCLA. Dr Miller received his medical degree from Columbia University College of Physicians and Surgeons in New York, and his Masters in Public Health from the University of California, Los Angeles. He completed an internship and residency at Harbor-UCLA Medical Center, a fellowship at the UCLA Multicampus Program in infectious diseases and microbial pathogenesis, and a fellowship with the UCLA/VA Multicampus Program in health services research. Dr Miller’s primary research interests include clinical outcomes, epidemiology, and molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections and skin infections. He has served as an investigator and principal investigator on many NIH, CDC, and AHQR grants related to treatment and prevention of MRSA and CA-MRSA, and has performed investigations related to HIV infection, urinary tract infections, Hepatitis B and C, and other infectious diseases topics. Dr Miller has authored several manuscripts relating to clinical and epidemiologic issues, and is an author on over 70 peer-reviewed manuscripts and book chapters.
  • David Talan, MD, FACEP, FAAEM, FIDSA

    David Talan, MD, FACEP, FAAEM, FIDSA

    David Talan, MD, FACEP, FAAEM, FIDSA

    Department of Medicine

    Dr. Talan received his medical degree from the University of Illinois Medical College in Chicago. He completed his residencies in Internal and Emergency Medicine and fellowship in Infectious Diseases at the University of California Los Angeles (UCLA) and its associated medical centers. He is board certified in Internal Medicine, Emergency Medicine, and Infectious Diseases.

    Dr. Talan was Chairman of the Olive View UCLA Department of Emergency Medicine from 1993 to 2014. He is faculty of the Department of Emergency Medicine and Department of Medicine, Division of Infectious Diseases at Olive View UCLA Medical Center. He is Professor of Medicine in Residence (Emeritus) at The David Geffen School of Medicine at UCLA. He is a Fellow of the American College of Emergency Physicians and the Infectious Diseases Society of America. Dr. Talan serves on the editorial boards of the Annals of Emergency Medicine, Emergency Medicine News, and Pediatric Emergency Care and is a reviewer for many journals including Clinical Infectious Diseases, JAMA, and The Medical Letter.
  • Elizabeth D. Barnett, MD

    Elizabeth D. Barnett, MD

    Elizabeth D. Barnett, MD

    Professor of Pediatrics

    Elizabeth D. Barnett, MD, is professor of pediatrics at the Boston University School of Medicine. She earned her medical degree from the Boston University School of Medicine, completed her residency at Boston City Hospital and Children’s Hospital, Boston, and completed a pediatric infectious disease fellowship at Boston City Hospital. Dr Barnett is board certified in pediatrics and pediatric infectious disease, and holds special interest in immigrant and refugee health, travel medicine, and immunizations.
  • Lin Hwei Chen, MD

    Lin Hwei Chen, MD

    Lin Hwei Chen, MD

    Director, Travel Medicine Center

    Lin H. Chen, MD, FACP, FASTMH, is the director of the Travel Medicine Center at Mount Auburn Hospital in Cambridge, Massachusetts, and associate professor of medicine at Harvard Medical School. She is a fellow of the American College of Physicians and the American Society of Tropical Medicine and Hygiene (ASTMH), serves on the Professional Education and Training Committee of the International Society of Travel Medicine (ISTM), and is an associate chair of the Scientific Program Committee for CISTM15 in Barcelona, Spain. Dr Chen is a member of the ASTMH’s Certificate Examination Committee and has contributed to the Journal of Travel Medicine, Current Infectious Disease Reports and Travel Medicine and Infectious Diseases, as well as the book Infectious Diseases: A Geographic Guide.
  • Paul E. Sax, MD

    Paul E. Sax, MD

    Paul E. Sax, MD

    Professor of Medicine

    Paul E. Sax, MD, is clinical director of the Division of Infectious Diseases and the HIV Program at Brigham and Women's Hospital (BWH), and professor of medicine at Harvard Medical School in Boston, Massachusetts. His ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. Dr Sax is presently the principal investigator at the BWH AIDS Clinical Trials Unit, a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group, and editor-in-chief of Open Forum Infectious Diseases. He earned his MD from Harvard Medical School, completed an internal medicine residency at BWH, and an infectious diseases fellowship at Massachusetts General Hospital.
  • John T. Brooks, MD

    John T. Brooks, MD

    John T. Brooks, MD

    Medical Epidemiologist, Division of HIV/AIDS Prevention

    John T. Brooks, MD is a medical epidemiologist with the Centers for Disease Control and Prevention in the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. He leads the Epidemiology Research Team in the CDC’s Division of HIV/AIDS Prevention that sponsors the HIV Outpatient Study which, since 1993, tracks the health of individuals living with HIV infection to improve prevention and treatment services. Dr Brooks is a nationally known expert in HIV-related opportunistic infections, complications of long-term survival and aging with HIV, and the use HIV medicines to prevent HIV transmission. He serves on numerous national HIV guidelines committees and has authored or coauthored over 140 peer-reviewed publications.
  • Linda Spooner, PharmD, RPh, BCPS, FASHP

    Linda Spooner, PharmD, RPh, BCPS, FASHP

    Linda Spooner, PharmD, RPh, BCPS, FASHP

    Professor of Pharmacy Practice

    Linda Spooner, PharmD, RPh, BCPS, FASHP, is professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences (MCPHS) School of Pharmacy-Worcester/Manchester and a clinical pharmacy specialist in infectious diseases at Saint Vincent Hospital in Worcester, Massachusetts. She conducts research in HIV pharmacotherapy, including assessment of medication errors with antiretroviral therapy in hospitalized patients, and spearheads initiatives to facilitate safe and appropriate use of antiretroviral therapy within the hospital setting. Dr Spooner is a fellow of the American Society of Health-System Pharmacists, is published in peer-reviewed journals, writes textbook chapters on antiretroviral therapy, and provides continuing education sessions for pharmacists.
  • Joanne Cono, MD, ScM

    Joanne Cono, MD, ScM

    Joanne Cono, MD, ScM

    Director, Office of Science Quality

    Joanne Cono is the Director of CDC’s Office of Science Quality. A board-certified pediatrician trained at the Children’s Hospital of Pittsburgh, Dr. Cono completed a Community Pediatrics and Child Advocacy fellowship at the Albert Einstein College of Medicine and has practiced pediatrics in the New York City homeless shelter system and at Egleston Children’s Hospital in Atlanta. She has a Master of Science degree in Vaccine Science and International Health from the Johns Hopkins School of Hygiene and Public Health, was a fellow in public health genetics at CDC, and a visiting faculty member at the University of Tartu in Estonia, teaching Epidemiology and Pediatrics. Dr. Cono joined CDC in 2000 as a medical epidemiologist in the National Immunization Program where she worked on childhood vaccine-preventable diseases and as an Associate Director for Science. She also has been an Associate Director for Science and Senior Medical Officer in the CDC Coordinating Office for Terrorism Preparedness and Emergency Response, as well as in the Bioterrorism Preparedness and Response Program of the National Center for Infectious Diseases where she was a lead for CDC’s smallpox vaccination and preparedness, as well as other bioterrorism preparedness activities. She was the lead of the Clinician Communications Team in CDC’s Emergency Communications System (ECS), developing emergency clinical guidance for medical and health professionals across the nation. More recently, Dr. Cono served as Senior Advisor for Global Health and as Senior Advisor for Science to the Director of CDC’s former Coordinating Center for Infectious Diseases, and as Senior Advisor for Science Integration to the Director of the current Office of Infectious Diseases. She has participated in numerous CDC public health emergency responses and led the Epidemiologic Response Team during the U.S. monkeypox outbreak response of 2003, and was Chief Health Officer in CDC’s emergency response to the 2010 earthquake in Haiti. Her areas of interest are emerging infectious diseases, emergency response, global health, and immunization.